Abstract
This research aims to investigate the moderating role of an economic crisis in the consumer purchase intention toward generic drugs (GDs), and it uses a quantitative questionnaire survey to collect data through face-to-face interviews and robust statistical analyses. The results reinforce the idea that price is a fundamental element in building pharmaceutical product value. In situations of limited resources, the cost savings from generic drugs represent a strong appeal to consumers' experience of GDs and closes the perceived quality gap between the brand name and the generic products. This research highlights two main contributions, and its findings provides managerial and political implications.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
